20 studies found for:    Open Studies | "Gout"
Show Display Options
Rank Status Study
1 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
2 Recruiting Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo
3 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
4 Not yet recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
5 Recruiting Arthritis Research UK Gout Treatment Trial - Phase 2
Condition: Gout
Interventions: Other: Nurse intervention;   Other: Standard care
6 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
7 Recruiting Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
Condition: Gout
Interventions: Drug: Arhalofenate 600 mg;   Drug: Allopurinol 300 mg;   Drug: Colchicine 0.6 mg;   Drug: Placebo;   Drug: Arhalofenate 800 mg
8 Not yet recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
Conditions: Gout;   Moderate Renal Impairment
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
9 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
10 Recruiting Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia
Condition: Gout and Hyperuricemia
Interventions: Drug: RDEA3170;   Drug: Allopurinol;   Drug: Placebo
11 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
12 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
13 Recruiting Effects of Fasting on Self Efficacy
Conditions: Chronic Pain;   Fibromyalgia;   Rheumatoid Arthritis;   Gout;   Headache;   Arthritis;   Gastrointestinal Diseases;   Irritable Bowel Syndrome;   Inflammatory Bowel Disease;   Cardiovascular Diseases
Intervention: Behavioral: Fasting
14 Not yet recruiting Mild, Moderate and Severe Renal Impairment Study
Condition: Gout
Intervention: Drug: RDEA3170
15 Recruiting Hereditary Tubulointerstitial Nephritis
Conditions: Nephritis, Interstitial;   Chronic Renal Failure;   Gout;   Renal Cysts
Intervention: Other: Blood and urine sample collections
16 Unknown  Safety and Efficacy Study of Intramuscular Uricase-PEG 20
Conditions: Gout;   Hyperuricemia
Intervention: Biological: Uricase-PEG 20
17 Unknown  Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
18 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Drug: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide
19 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
20 Recruiting Role of ASICs in Human Inflammatory Pain
Conditions: Arthritis;   Osteoarthritis;   Chondrocalcinosis;   Gouty Arthritis;   Rheumatoid Arthritis
Intervention:

Indicates status has not been verified in more than two years